Concord Medical Services (CCM) Stock Price, News & Analysis

Company Overview

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China. The company typically partners with top-tier public hospitals to establish dedicated radiotherapy departments, combining its proprietary equipment management system with on-site technical teams. This collaborative approach allows hospital partners to expand access to high-precision treatment modalities, while Concord Medical Services oversees installation, quality assurance and ongoing clinical training for medical staff.

In addition to equipment provision, Concord Medical Services offers comprehensive consulting services that encompass treatment protocol design, dosimetry verification and patient data management. The company’s technology platform integrates imaging, treatment planning and delivery data, enabling clinicians to streamline workflows and monitor outcomes in real time. Concord Medical Services also provides preventive maintenance and rapid-response repair services, ensuring minimal downtime for critical cancer therapy equipment.

Since its initial public offering on the New York Stock Exchange in 2016, Concord Medical Services has continued to expand its footprint by pursuing new hospital partnerships and exploring advanced modalities such as image-guided radiotherapy and proton therapy. With a focus on innovation and quality assurance, the company aims to address the growing demand for precision oncology services across China’s rapidly aging and urbanizing population.

Key Stats

• Today's Range: $4.31 to $4.88
• 50-Day Range: $3.52 to $5.42
• 52-Week Range: $3.18 to $10.77
• Volume: 41,926 shs
• Average Volume: 43,740 shs
• Market Capitalization: $20.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Concord Medical Services Stock Analysis - MarketRank™

Concord Medical Services scored higher than 9% of companies evaluated by MarketBeat, and ranked 818th out of 849 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Concord Medical Services has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Concord Medical Services has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Concord Medical Services has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.35% of the float of Concord Medical Services has been sold short.

Short Interest Ratio / Days to Cover

Concord Medical Services has a short interest ratio ("days to cover") of 0.24, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Concord Medical Services has recently increased by 8.78%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Concord Medical Services does not currently pay a dividend.

Dividend Growth

Concord Medical Services does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Concord Medical Services insiders have not sold or bought any company stock.

Percentage Held by Insiders

46.50% of the stock of Concord Medical Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Concord Medical Services has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 4/29/2026
• Today: 6/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - NURSING HMS
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CCM
• CIK: 1472072
• Web: www.concordmedical.com
• Phone: 861059036688
• Fax: 86-10-5957-5252
• Employees: 970
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.33
• Current Ratio: 0.48
• Quick Ratio: 0.46

Sales & Book Value

• Annual Sales: $65.85 million
• Price / Sales: 0.31
• Cash Flow: $1.90 per share
• Price / Cash Flow: 2.45
• Book Value: $60.94 per share
• Price / Book: 0.08

Miscellaneous

• Outstanding Shares: 4,340,000
• Free Float: 2,323,000
• Market Cap: $20.16 million
• Optionable: Not Optionable
• Beta: -0.99